Dr. Julian Adin Abrams, MD

Dr. Abrams practices at Columbia University Irving Medical Center in New York, New York.

Dr. Abrams' NPI, 1669494746, was assigned on July 24, 2006. Dr. Abrams graduated from Icahn School Of Medicine At Mount Sinai in 2000. Dr. Abrams holds New York license 224312.

Dr. Abrams' primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Abrams' primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Abrams is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Abrams to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abrams practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Abrams' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Abrams is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Abrams' licenses on file in 2 states: New York and New Jersey.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, gastroenteritis, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Abrams treats.

CMS data shows 293 Medicare services from Dr. Abrams across 6 procedure codes in 2024, for 183 Medicare patients. Medicare paid $26,321 for them.

CMS counts 183 Medicare patients who saw Dr. Abrams in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abrams' median patient age at 72, with 36% women.

In 2024, Dr. Abrams wrote 623 Medicare Part D claims for 145 patients. 89% of them were for generic drugs. CMS names the drug for 532 of them, across 11 drugs with 11 or more claims each, at $29,620 in total drug cost. In 2023, CMS named 513 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Abrams for performance year 2024, reported through an alternative payment model (APM). Dr. Abrams accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abrams as offering telehealth. CMS counts 139 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Abrams, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 143 papers to Dr. Abrams, published from 2006 to 2025. 2020 was the busiest year, with 11. The most frequent topics are Esophageal Neoplasms, Barrett Esophagus and Adenocarcinoma. Dr. Abrams has published most often in Gastroenterology. Dr. Abrams' most frequent co-authors are Daniel Ezra Freedberg, MD, Charles J. Lightdale, MD and Timothy Cragin Wang, MD.

Dmand AI links Dr. Abrams to 12 clinical trials. 2 are still active or recruiting. Conditions studied include Barrett Esophagus, Precancerous Conditions and Adenocarcinoma Of Esophagus. Columbia University sponsors the most, 6.

CMS Open Payments shows 19 general payments to Dr. Abrams from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 61% of the total. Covidien LP paid the most, $7,128.

Dr. Abrams graduated from Icahn School Of Medicine At Mount Sinai in 2000.

Dr. Abrams is in network with 11 carriers, including Aetna, Excellus BlueCross BlueShield and MVP Health Care. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.